Effects of percutaneous transluminal renal angioplasty on systemic blood pressure evaluated with 24-hour monitoring

Effects of percutaneous transluminal renal angioplasty on systemic blood pressure evaluated with 24-hour monitoring - Effects of percutaneous transluminal renal angioplasty on systemic blood pressure evaluated with 24-hour monitoring

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017110

Enrollment

Registered

2015-04-12

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renovascular hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the following conditions. 1. Patients suffering refractory hypertension who presented systolic BP >140 mmHg documented at least 3 times on different clinic visit under two or more antihypertensive medications. 2. Patients with angiographically severe stenosis in renal artery were tested for translesional pressure gradient (TLPG) by pressure detectable wire (Pressure Wire Certus, St. Jude Medical) under hyperemic condition that was induced by intrarenal artery administration of 30 mg of papaverine.

Exclusion criteria

Exclusion criteria: Patients on regular hemodialysis, or patients without written informed consent.

Design outcomes

Primary

Measure	Time frame
24-hour systemic blood pressure at 1-month after PTRA	—

Secondary

Measure	Time frame
24-hour systemic blood pressure at 12-month after PTRA	—

Countries

Japan

Contacts

Public ContactKentaro Jujo

Nishiarai Heart Center Hospitalart Department of Cardiology

juken1123@hotmail.co.jp+81358380730

Outcome results